Ratings Barry Callebaut AG OTC Markets

Equities

BYCBF

CH0009002962

Delayed OTC Markets Other stock markets 14:46:17 06/05/2024 BST			5-day change	1st Jan Change
1,727 ^USD	-0.48%		+15.11%	+5.88%

05-06	Ivory Coast cocoa exporters ask regulator for support	RE
04-26	Barry Callebaut Accepts Penalty for Negligent Publishing of FY22 Financial Report	MT

Strengths

Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
The firm trades with high earnings multiples: 30.7 times its 2024 earnings per share.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
For the past year, analysts have significantly revised downwards their profit estimates.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Food Processing

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
BARRY CALLEBAUT AG	+5.88%	9.19B		-
LINDT	+4.12%	26.94B		B+
TOOTSIE ROLL INDUSTRIES, INC.	-7.17%	2.13B	-	D
MORINAGA&CO., LTD.	-0.94%	1.5B		-
JOHN B. SANFILIPPO & SON, INC.	-3.45%	1.14B	-	C
GUAN CHONG	+58.47%	719M		B-
CLOETTA AB	-2.84%	470M		B+
DELFI LIMITED	-20.54%	398M		C+
JOSEF MANNER & COMP. AG	-0.90%	224M	-	-
WAWEL S.A.	-10.67%	217M		-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes